NCT03579420 is a NA clinical trial of Brief lifestyle program in Diabetes Mellitus, Type 2, sponsored by Azienda Ospedaliero-Universitaria Careggi.

Who is sponsoring NCT03579420?

NCT03579420 is sponsored by Azienda Ospedaliero-Universitaria Careggi.

What drugs are being tested in NCT03579420?

Interventions in NCT03579420: Brief lifestyle program, Conventional lifestyle program.

What condition does NCT03579420 study?

NCT03579420 studies Diabetes Mellitus, Type 2.

Is NCT03579420 still recruiting?

NCT03579420 is currently status unknown. Last updated 13 January 2021.

Last reviewed 2021-01-13 · How we verify

NCT03579420

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Efficacy of a Brief Lifestyle Intervention in Type 2 Diabetes, Compared With a Longer Group Educational Program

Status unknown NA Last updated 13 January 2021

What this trial tests

NA trial testing Brief lifestyle program in Diabetes Mellitus, Type 2 in 226 participants. Status unknown.

Timeline

1 March 2018

Primary endpoint
1 October 2022

1 April 2024

Quick facts

Lead sponsor	Azienda Ospedaliero-Universitaria Careggi
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	treatment
Enrollment	226
Start date	1 March 2018
Primary completion	1 October 2022
Estimated completion	1 April 2024
Sites	1 location across Italy

Drugs / interventions tested

Brief lifestyle program
Conventional lifestyle program

Conditions studied

Diabetes Mellitus, Type 2 — all drugs for Diabetes Mellitus, Type 2 →

Sponsor

Azienda Ospedaliero-Universitaria Careggi — full company profile →

Who can join

Adults 18 to 75, any sex, with Diabetes Mellitus, Type 2. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The study will compare two different programs for lifestyle intervention in type 2 diabetes: 1. A brief group program, with three weekly sessions 2. A longer group program, with six weekly sessions, which has been routinely used for the management of type 2 diabetic patients in this hospital for several years. The aim is that of demonstrating the non-inferiority of the new brief, and more sustainable, program, in comparison with the more traditional approach.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Diabetes Mellitus, Type 2

Currently open trials in the same condition.

NCT07415954 — A Research Study Comparing How Well Different Doses of the Medicine NNC0662-0419 Lower Blood Sugar in People With Type 2 · Phase 2 · recruiting
NCT07532863 — A Real-world Study to Investigate Cardiovascular Risk Profile Among Newly Diagnosed Type 2 Diabetes Mellitus (T2DM) Part · recruiting
NCT07336329 — Continuous Glucose Monitoring in Non-Insulin Treated Type 2 Diabetes: Continuous vs. Periodic Use · NA · recruiting
NCT07242469 — A Clinical Trial of MK-1403 in Participants With Type 2 Diabetes Mellitus (MK-1403-006) · Phase 1 · recruiting
NCT07444203 — Transformative Research in Diabetic Nephropathy 2.0 · recruiting

Other Azienda Ospedaliero-Universitaria Careggi trials

Trials by the same sponsor.

NCT07296055 — Endobronchial Valve in Tubercular and NTM Pulmonary Cavities. · NA · not yet recruiting
NCT07289581 — Effect of Treatment With Butyric Acid in Anorexia Nervosa · NA · active not recruiting
NCT06978608 — Ultrasound and Somatosensory Median Nerve Evaluation in CRPS I · not yet recruiting
NCT07005882 — Hormonal Receptor (HR)-Positive HER2 Negative Breast Cancer Patients Treated With Preoperative ELacestrant and PULSAR Ra · Phase 2 · not yet recruiting
NCT06529601 — Comparison Between CAD/CAM and Conventional Mandibular Fixed Retainers. · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03579420 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Azienda Ospedaliero-Universitaria Careggi
Last refreshed: 13 January 2021

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03579420.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing